Teknova
Healthcare Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2451 Bert Dr, Hollister, California, 950...Phone Number
(831) 637-1100Website
www.teknova.comRevenue
$43.7 MillionStock Symbol
TKNOIndustry
ZI Rank: 6
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
8
13
10
8
6
6
About Teknova
Founded in 1996, Teknova specializes in providing critical reagents for bioprocessing, bioproduction, and molecular diagnostics. Product offerings include cell culture media and supplements, protein purification buffers, and molecular biology reagents for the life sciences and healthcare communities. The company is headquartered in Hollister, California.Explore more
Teknova Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Teknova your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Teknova launches new products
Congratulate Masked Content for being promoted to Masked Content at Teknova
Website visits: Recent activity has been detected on your website
Click to see if Teknova had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Teknova has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Teknova recently announced quarterly report
Check out if Teknova is spiking on competitors!
Teknova, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Teknova has new funding data
Recommended Actions
Find VP level buyers at Teknova
Find 3 more new buyers
Compare Similar Companies to Teknova
Compare insights from companies similar to Teknova, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Teknova is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Teknova is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Teknova.
Teknova financials insights
Gather financial insights about Teknova, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Stock Offering
$96M
Teknova Tech Stack
A closer look at the technologies used by Teknova
Most Recent Scoops
Earnings
Teknova has reported revenues of $12.2 million for Q2, representing 18% revenue growth and the largest quarterly revenue in the company's history. As a result, Teknova raised its full-year revenue guidance from a range of $42 to $44 million to a new range of $45 to $47 million, reflecting mid-to-high teens growth for the year.
Earnings, Finance
Earnings
Teknova has reported $17.4 million in cash equivalents and short-term investments and $13.2 million in total borrowings as of June 30, 2026.
Earnings, Business Finance, Finance
Earnings
expects to achieve adjusted EBITDA positivity at an annualized revenue range of $52 million to $57 million, with a positive adjusted EBITDA quarter potentially reported before the end of 2027 if end markets strengthen and commercial investments perform as anticipated.
Earnings, Forecasting, Finance, Financial Operations
Earnings
now expects full-year 2026 gross margin to land in the mid to upper 30s percent range.
Earnings, Finance
Earnings
Earnings, Finance
Teknova News & Media
Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference
Alpha Teknova (NASDAQ:TKNO) Chief Financial Officer Matt Lowell said the provider of laboratory and bioprocessing reagents is seeing renewed growth, reporting record second-quarter revenue and raising its full-year outlook as biopharma funding and life-science end markets improve. Speaking at the STeknova Reports Second Quarter 2026 Financial Results
Teknova reports Q2:26 earnings with total revenue of $12.2 million, up 18% over same quarter prior year, and raises 2026 guidance to $45-47 millionTeknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes
Teknova's Build-Tek Custom Configurator, built using AI, enables therapeutic and diagnostic customers to easily design complex custom reagents in minutes.Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026
HOLLISTER, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2026, on Wednesday, August 5, 2026, following the close of market.
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Teknova
Sign Up For FreeTo access detailed company insights
Founded in 1996, Teknova specializes in providing critical reagents for bioprocessing, bioproduction, and molecular diagnostics. Product offerings include cell culture media and supplements, protein purification buffers, and molecular biology reagents for the life sciences and healthcare communities. The company is headquartered in Hollister, Calif... Read More
